Effects and Mechanisms of Vitamin C Post-Conditioning on Platelet Activation after Hypoxia/Reoxygenation

Effects and Mechanisms of Vitamin C Post-Conditioning on Platelet Activation after Hypoxia/Reoxygenation

Background: Platelet activation occurs upon ischemia/reperfusion and is related to the generation of reactive oxygen species (ROS) during this process. Vitamin C (VC) is a powerful antioxidant. VC scavenges ROS, reduces platelet activation, and attenuates reperfusion injury. However, the effects of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transfusion medicine and hemotherapy 2020-04, Vol.47 (2), p.110-118
Hauptverfasser: Liu, Demin, Pei, Dongguo, Hu, Haijuan, Gu, Guoqiang, Cui, Wei
Format: Artikel
Sprache:eng
Schlagworte:
Research Article
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 118
container_issue 2
container_start_page 110
container_title Transfusion medicine and hemotherapy
container_volume 47
creator Liu, Demin
Pei, Dongguo
Hu, Haijuan
Gu, Guoqiang
Cui, Wei
description Background: Platelet activation occurs upon ischemia/reperfusion and is related to the generation of reactive oxygen species (ROS) during this process. Vitamin C (VC) is a powerful antioxidant. VC scavenges ROS, reduces platelet activation, and attenuates reperfusion injury. However, the effects of VC on platelets undergoing hypoxia/reoxygenation (H/R) remain unclear. Objectives: Herein, we evaluated the effects of VC on platelets in vitro following H/R and the related mechanisms. Method: Fresh platelets were collected from 67 volunteers at the Blood Center of Hebei Province. Platelets were diluted with saline to a concentration of 2.00 × 10 11 /L. Aggregation and the curve slope were evaluated within 4 h with a whole-blood impedance analyzer. To determine the optimal experimental time, platelets were treated with hypoxia or reoxygenation for different times, and impedance aggregometry was carried out by measuring changes in electrical impedance induced by arachidonic acid (0.5 mM) and adenosine diphosphate (10 µM), thereby establishing the H/R model. Three antioxidants (VC, melatonin, and probucol) were used to treat platelets after H/R, and impedance aggregometry was used to determine their effects on platelet aggregation. The influence of VC on apoptosis-related indicators was detected. ROS and the mitochondrial membrane potential were observed by inverted fluorescence microscopy and flow cytometry, respectively. Related protein levels were detected by Western blotting. Results: ROS scavengers inhibited platelet activation and aggregation in a concentration-dependent manner. VC post-conditioning scavenged ROS, downregulated cytochrome C, Bax, and caspase-9 proteins, and upregulated Bcl-2 protein. These effects collectively blocked platelet apoptosis and inhibited platelet aggregation. Conclusions: VC inhibited platelet aggregation by blocking apoptosis. Thus, VC may have applications in the treatment of platelet-related diseases.
doi_str_mv 10.1159/000500492
format Article
fullrecord <record><control><sourceid>proquest_karge</sourceid><recordid>TN_cdi_karger_primary_500492</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2397670620</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-a752ce2d4a73a290575e2e8e3b05b539d00b1d11ecaaf41ddabd07c10a9097633</originalsourceid><addsrcrecordid>eNptkc1rFEEQxQdRTIwevIs05JIcxlR3T8_HRQhLdIUEg0SvTU13zW7rTPc63Ruy_72TbDIoeKqC96v3Cl6WveXwgXPVnAGAAiga8Sw75GUJuax5_fxpr5ryIHsV408AUdRSvMwOpJBKFRUcZuuLriOTIkNv2RWZNXoXh8hCx364hIPzbMGuQ0z5Injrkgve-RULnl33mKinxM5Ncrd4rzDsEo1suduEO4dn3yjc7VbkH7TX2YsO-0hvHudR9v3Txc1imV9-_fxlcX6Zm0IUKcdKCUPCFlhJFA2oSpGgmmQLqlWysQAtt5yTQewKbi22FirDARtoqlLKo-zj3nezbQeyhnwasdeb0Q047nRAp_9VvFvrVbjVFa-Luigng5NHgzH83lJMenDRUN-jp7CNWsgpp4JSwISe7lEzhhhH6uYYDvq-GT03M7Hv__5rJp-qmIB3e-AXjisaZ2C-P_6vfHO13BN6Yzv5BzLbn60</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2397670620</pqid></control><display><type>article</type><title>Effects and Mechanisms of Vitamin C Post-Conditioning on Platelet Activation after Hypoxia/Reoxygenation</title><source>Karger Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Liu, Demin ; Pei, Dongguo ; Hu, Haijuan ; Gu, Guoqiang ; Cui, Wei</creator><creatorcontrib>Liu, Demin ; Pei, Dongguo ; Hu, Haijuan ; Gu, Guoqiang ; Cui, Wei</creatorcontrib><description>Background: Platelet activation occurs upon ischemia/reperfusion and is related to the generation of reactive oxygen species (ROS) during this process. Vitamin C (VC) is a powerful antioxidant. VC scavenges ROS, reduces platelet activation, and attenuates reperfusion injury. However, the effects of VC on platelets undergoing hypoxia/reoxygenation (H/R) remain unclear. Objectives: Herein, we evaluated the effects of VC on platelets in vitro following H/R and the related mechanisms. Method: Fresh platelets were collected from 67 volunteers at the Blood Center of Hebei Province. Platelets were diluted with saline to a concentration of 2.00 × 10 11 /L. Aggregation and the curve slope were evaluated within 4 h with a whole-blood impedance analyzer. To determine the optimal experimental time, platelets were treated with hypoxia or reoxygenation for different times, and impedance aggregometry was carried out by measuring changes in electrical impedance induced by arachidonic acid (0.5 mM) and adenosine diphosphate (10 µM), thereby establishing the H/R model. Three antioxidants (VC, melatonin, and probucol) were used to treat platelets after H/R, and impedance aggregometry was used to determine their effects on platelet aggregation. The influence of VC on apoptosis-related indicators was detected. ROS and the mitochondrial membrane potential were observed by inverted fluorescence microscopy and flow cytometry, respectively. Related protein levels were detected by Western blotting. Results: ROS scavengers inhibited platelet activation and aggregation in a concentration-dependent manner. VC post-conditioning scavenged ROS, downregulated cytochrome C, Bax, and caspase-9 proteins, and upregulated Bcl-2 protein. These effects collectively blocked platelet apoptosis and inhibited platelet aggregation. Conclusions: VC inhibited platelet aggregation by blocking apoptosis. Thus, VC may have applications in the treatment of platelet-related diseases.</description><identifier>ISSN: 1660-3796</identifier><identifier>EISSN: 1660-3818</identifier><identifier>DOI: 10.1159/000500492</identifier><identifier>PMID: 32355470</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger GmbH</publisher><subject>Research Article</subject><ispartof>Transfusion medicine and hemotherapy, 2020-04, Vol.47 (2), p.110-118</ispartof><rights>2019 The Author(s)Published by S. Karger AG, Basel</rights><rights>Copyright © 2019 by S. Karger AG, Basel.</rights><rights>Copyright © 2019 by S. Karger AG, Basel 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-a752ce2d4a73a290575e2e8e3b05b539d00b1d11ecaaf41ddabd07c10a9097633</citedby><cites>FETCH-LOGICAL-c424t-a752ce2d4a73a290575e2e8e3b05b539d00b1d11ecaaf41ddabd07c10a9097633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184846/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184846/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,2423,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32355470$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Demin</creatorcontrib><creatorcontrib>Pei, Dongguo</creatorcontrib><creatorcontrib>Hu, Haijuan</creatorcontrib><creatorcontrib>Gu, Guoqiang</creatorcontrib><creatorcontrib>Cui, Wei</creatorcontrib><title>Effects and Mechanisms of Vitamin C Post-Conditioning on Platelet Activation after Hypoxia/Reoxygenation</title><title>Transfusion medicine and hemotherapy</title><addtitle>Transfus Med Hemother</addtitle><description>Background: Platelet activation occurs upon ischemia/reperfusion and is related to the generation of reactive oxygen species (ROS) during this process. Vitamin C (VC) is a powerful antioxidant. VC scavenges ROS, reduces platelet activation, and attenuates reperfusion injury. However, the effects of VC on platelets undergoing hypoxia/reoxygenation (H/R) remain unclear. Objectives: Herein, we evaluated the effects of VC on platelets in vitro following H/R and the related mechanisms. Method: Fresh platelets were collected from 67 volunteers at the Blood Center of Hebei Province. Platelets were diluted with saline to a concentration of 2.00 × 10 11 /L. Aggregation and the curve slope were evaluated within 4 h with a whole-blood impedance analyzer. To determine the optimal experimental time, platelets were treated with hypoxia or reoxygenation for different times, and impedance aggregometry was carried out by measuring changes in electrical impedance induced by arachidonic acid (0.5 mM) and adenosine diphosphate (10 µM), thereby establishing the H/R model. Three antioxidants (VC, melatonin, and probucol) were used to treat platelets after H/R, and impedance aggregometry was used to determine their effects on platelet aggregation. The influence of VC on apoptosis-related indicators was detected. ROS and the mitochondrial membrane potential were observed by inverted fluorescence microscopy and flow cytometry, respectively. Related protein levels were detected by Western blotting. Results: ROS scavengers inhibited platelet activation and aggregation in a concentration-dependent manner. VC post-conditioning scavenged ROS, downregulated cytochrome C, Bax, and caspase-9 proteins, and upregulated Bcl-2 protein. These effects collectively blocked platelet apoptosis and inhibited platelet aggregation. Conclusions: VC inhibited platelet aggregation by blocking apoptosis. Thus, VC may have applications in the treatment of platelet-related diseases.</description><subject>Research Article</subject><issn>1660-3796</issn><issn>1660-3818</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><recordid>eNptkc1rFEEQxQdRTIwevIs05JIcxlR3T8_HRQhLdIUEg0SvTU13zW7rTPc63Ruy_72TbDIoeKqC96v3Cl6WveXwgXPVnAGAAiga8Sw75GUJuax5_fxpr5ryIHsV408AUdRSvMwOpJBKFRUcZuuLriOTIkNv2RWZNXoXh8hCx364hIPzbMGuQ0z5Injrkgve-RULnl33mKinxM5Ncrd4rzDsEo1suduEO4dn3yjc7VbkH7TX2YsO-0hvHudR9v3Txc1imV9-_fxlcX6Zm0IUKcdKCUPCFlhJFA2oSpGgmmQLqlWysQAtt5yTQewKbi22FirDARtoqlLKo-zj3nezbQeyhnwasdeb0Q047nRAp_9VvFvrVbjVFa-Luigng5NHgzH83lJMenDRUN-jp7CNWsgpp4JSwISe7lEzhhhH6uYYDvq-GT03M7Hv__5rJp-qmIB3e-AXjisaZ2C-P_6vfHO13BN6Yzv5BzLbn60</recordid><startdate>20200401</startdate><enddate>20200401</enddate><creator>Liu, Demin</creator><creator>Pei, Dongguo</creator><creator>Hu, Haijuan</creator><creator>Gu, Guoqiang</creator><creator>Cui, Wei</creator><general>S. Karger GmbH</general><scope>M--</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200401</creationdate><title>Effects and Mechanisms of Vitamin C Post-Conditioning on Platelet Activation after Hypoxia/Reoxygenation</title><author>Liu, Demin ; Pei, Dongguo ; Hu, Haijuan ; Gu, Guoqiang ; Cui, Wei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-a752ce2d4a73a290575e2e8e3b05b539d00b1d11ecaaf41ddabd07c10a9097633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Research Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Demin</creatorcontrib><creatorcontrib>Pei, Dongguo</creatorcontrib><creatorcontrib>Hu, Haijuan</creatorcontrib><creatorcontrib>Gu, Guoqiang</creatorcontrib><creatorcontrib>Cui, Wei</creatorcontrib><collection>Karger Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Transfusion medicine and hemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Demin</au><au>Pei, Dongguo</au><au>Hu, Haijuan</au><au>Gu, Guoqiang</au><au>Cui, Wei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects and Mechanisms of Vitamin C Post-Conditioning on Platelet Activation after Hypoxia/Reoxygenation</atitle><jtitle>Transfusion medicine and hemotherapy</jtitle><addtitle>Transfus Med Hemother</addtitle><date>2020-04-01</date><risdate>2020</risdate><volume>47</volume><issue>2</issue><spage>110</spage><epage>118</epage><pages>110-118</pages><issn>1660-3796</issn><eissn>1660-3818</eissn><abstract>Background: Platelet activation occurs upon ischemia/reperfusion and is related to the generation of reactive oxygen species (ROS) during this process. Vitamin C (VC) is a powerful antioxidant. VC scavenges ROS, reduces platelet activation, and attenuates reperfusion injury. However, the effects of VC on platelets undergoing hypoxia/reoxygenation (H/R) remain unclear. Objectives: Herein, we evaluated the effects of VC on platelets in vitro following H/R and the related mechanisms. Method: Fresh platelets were collected from 67 volunteers at the Blood Center of Hebei Province. Platelets were diluted with saline to a concentration of 2.00 × 10 11 /L. Aggregation and the curve slope were evaluated within 4 h with a whole-blood impedance analyzer. To determine the optimal experimental time, platelets were treated with hypoxia or reoxygenation for different times, and impedance aggregometry was carried out by measuring changes in electrical impedance induced by arachidonic acid (0.5 mM) and adenosine diphosphate (10 µM), thereby establishing the H/R model. Three antioxidants (VC, melatonin, and probucol) were used to treat platelets after H/R, and impedance aggregometry was used to determine their effects on platelet aggregation. The influence of VC on apoptosis-related indicators was detected. ROS and the mitochondrial membrane potential were observed by inverted fluorescence microscopy and flow cytometry, respectively. Related protein levels were detected by Western blotting. Results: ROS scavengers inhibited platelet activation and aggregation in a concentration-dependent manner. VC post-conditioning scavenged ROS, downregulated cytochrome C, Bax, and caspase-9 proteins, and upregulated Bcl-2 protein. These effects collectively blocked platelet apoptosis and inhibited platelet aggregation. Conclusions: VC inhibited platelet aggregation by blocking apoptosis. Thus, VC may have applications in the treatment of platelet-related diseases.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger GmbH</pub><pmid>32355470</pmid><doi>10.1159/000500492</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1660-3796
ispartof Transfusion medicine and hemotherapy, 2020-04, Vol.47 (2), p.110-118
issn 1660-3796
1660-3818
language eng
recordid cdi_karger_primary_500492
source Karger Journals; PubMed Central; Alma/SFX Local Collection
subjects Research Article
title Effects and Mechanisms of Vitamin C Post-Conditioning on Platelet Activation after Hypoxia/Reoxygenation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T19%3A05%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_karge&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20and%20Mechanisms%20of%20Vitamin%20C%20Post-Conditioning%20on%20Platelet%20Activation%20after%20Hypoxia/Reoxygenation&rft.jtitle=Transfusion%20medicine%20and%20hemotherapy&rft.au=Liu,%20Demin&rft.date=2020-04-01&rft.volume=47&rft.issue=2&rft.spage=110&rft.epage=118&rft.pages=110-118&rft.issn=1660-3796&rft.eissn=1660-3818&rft_id=info:doi/10.1159/000500492&rft_dat=%3Cproquest_karge%3E2397670620%3C/proquest_karge%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2397670620&rft_id=info:pmid/32355470&rfr_iscdi=true